Visvin 30mg Dry Vial Of 1 Powder For Injection
Free
Contains – Decitabine(30.0 Mg)
Visvin 30 mg Injection belongs to the class of anticancer medicine. It contains decitabine as its active ingredient. It is used for the treatment of blood cancer called Acute myeloid leukaemia (AML) and Myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and not healthy). To ensure the safety of women of reproductive potential, it is strongly advised that they avoid pregnancy and utilise reliable contraception while receiving Visvin 30 mg Injection. This precautionary measure should be maintained for a period of 6 months following the completion of treatment. Similarly, men with female partners of reproductive potential should also practice effective contraception during the course of treatment and for 3 months after the last dose.
